Diversity and Bioprospecting Potential of Bacteria Isolated from the Arctic: A Preliminary Study by Sabu Thomas, Wilson P Abraham
Mapana J Sci, 12, 4(2013), 19-28 
 ISSN 0975-3303|doi:10.12723/mjs.27.3 
19 
 
Diversity and Bioprospecting Potential of 
Bacteria Isolated from the Arctic:  
A Preliminary Study 
Wilson P Abraham* and Sabu Thomas † 
Abstract 
Bioprospecting is a search for new or better bioproducts 
from biological sources preferably from novel 
biodiversity. Molecules derived from natural products, 
particularly those produced by plants and 
microorganisms, have an excellent record of providing 
novel chemical structures for development as new 
pharmaceuticals. Bacteria living under stress are best 
sources for bioprospecting and also these organisms are 
least explored. This paper focuses on the bioprospecting 
and biotechnological potential of bacteria isolated from 
the Polar Regions. In this context, let us have a glance 
through the major cold adaptations of psychrophiles and 
their application potentials with special reference to 
psychrophilic enzymes. Our lab focus on identifying the 
biofilm inhibitors against bacterial pathogens and novel 
molecules of medical importance from bacteria and 
actinomycetes isolated from Arctic, the North Pole. We 
are also interested in profiling the diversity, multidrug 
resistance pattern and the molecular mechanisms 
involved in bacteria isolated from the pristine 
environment.  
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Introduction 
Bioprospecting relies on provision of a bioresource, a supply of 
novel biodiversity. Many of the world's most successful and 
valuable pharmaceuticals have been derived directly or indirectly 
from natural product sources eg. acetylsalicilic acid (aspirin) from 
willow bark and penicillin from the fungus Penicillium. Extreme 
environments provide microorganisms containing robust enzymes. 
Such microorganisms that flourish in extremes of temperature, 
pressure, acidity or alkalinity are sources of extremophilic enzymes 
that are required by many industrial processes. Bioprospecting for 
such enzymes involves culturing and isolation of novel 
extremophiles from polar habitats. Microorganisms represent the 
largest reservoir of unexplored biodiversity, and hence possess the 
greatest potential for the discovery of new natural products. 
Microbial adaptations to cold environments  
Investigations of sea ice and glacial microbial communities have 
demonstrated the dominance of bacterial populations highly 
adapted to life at constant low temperature. These bacteria are 
known as ―psychrophiles‖. The term "psychrophile" (psychro- cold, 
phile- loving) was first coined in 1902 to describe bacteria capable of 
growth and survival at 0°C [1]. Microbial adaptation to a 
permanently cold environment includes the optimization of basic 
cell processes necessary for growth and survival. These can be 
summarized into three categories; enzyme function, nutrient 
transport and cell membrane function. A typical example is the 
protein profiling studies done on the cold adapted bacteria 
Methanococcus burtonii [2]. The adaptations of cellular processes in 
each of these areas represent potential biotechnology products for 
exploitation. Two examples are the production of polyunsaturated 
fatty acids (PUFA) and the production of cold-active enzymes by 
bacteria from Arctic and Antarctic sea ice. 
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Protein synthesis, cold-acclimation proteins and antifreeze 
proteins 
Transcription and translation are temperature-sensitive steps and 
psychrophiles have obviously adapted the process of protein 
synthesis to low temperatures. It is expected that the enzymatic 
activities that are involved in protein synthesis have the general 
traits of cold-adapted enzymes — high activity associated with low 
stability — but this aspect has not been consistently analysed so far. 
However, low temperatures strengthen the interactions between 
DNA strands in the double helix and in the supercoiled state, 
therefore impairing unwinding and access to RNA polymerase. 
Low temperatures also promote unfavorable RNA secondary 
structures, which are likely to interfere with translation. 
Accordingly, it is expected that nucleic acid binding proteins, 
which relieve the adverse effects of low temperatures, have a 
central role in the cold adaptation of psychrophiles [3-5]. In this 
respect, it is significant that the five unique genes that have been 
detected in the genome of two cold-adapted Archaea are predicted 
to encode nucleic acid binding proteins [6]. In an Antarctic 
archaeon, the gene transcript for an RNA helicase, which possibly 
removes cold-stabilized secondary structures, is accumulated 
during growth at 4°C, but is undetectable at 23°C [7]. Moreover, 
increased post-transcriptional incorporation of dihydrouridine in 
tRNA from psychrophilic bacteria is thought to improve the 
conformational flexibility of RNA [8].  
Cold-acclimation proteins (CAPs) seem to be another important 
and general feature of cold-adapted microorganisms [9]. A set of 
~20 proteins is permanently synthesized during steady-state 
growth at low temperatures, but not at milder temperatures [10, 
11]. Interestingly, some of the few CAPs that have been identified 
in cold-adapted bacteria are cold-shock proteins in mesophiles, 
such as the RNA chaperone CspA [12]. It has been proposed that 
these CAPs are essential for the maintenance of both growth and 
the cell cycle at low temperatures [9],but their function is still 
poorly understood. Antifreeze proteins have been widely studied 
in polar fish [13].These peptides and glycopeptides of various sizes 
decrease the freezing point of cellular water by binding to ice 
crystals during formation.   Although antifreeze proteins have been 
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reported in several eukaryotes, there is no supporting evidence for 
the occurrence of such glycopeptides in psychrophilic prokaryotes. 
Biotechnological applications of psychrophilic enzymes 
The high activity of psychrophilic enzymes at low and moderate 
temperatures offers potential economic benefits [3, 14-18]through 
substantial energy savings in large-scale processes that would not 
require the expensive heating of reactors. A typical example is the 
industrial ‗peeling‘ of leather by proteases, which can be done at 
the temperature of tap water by cold-active enzymes instead of 
heating to 37°C for the process to be performed by mesophilic 
enzymes. Psychrophilic enzymes can also be useful in domestic 
processes. For instance, washing clothes at low temperatures can 
protect the colours of fabrics (and reduce energy consumption), but 
enzymes that are added to detergents to hydrolyse macromolecular 
stains -for example, subtilisin, lipase and glycosidases etc are 
poorly active at the temperature of tap water; they can be 
substituted by psychrophilic enzymes. In the food industry, their 
properties allow the transformation or refinement of heat-sensitive 
products. Lactose intolerance is a problem for approximately two-
thirds of the world‘s population. The removal of lactose from milk 
by a psychrophilic β-galactosidase during cold storage has recently 
been patented.As another example, cold-active pectinases can help 
to reduce viscosity and clarify fruit juices at low temperatures. The 
heat-lability of these enzymes also ensures their fast, efficient and 
selective inactivation in complex mixtures. The use of a heat-labile 
alkaline phosphatase in molecular biology (which does not 
interfere with end labeling by polynucleotide kinase after heat 
treatment) is probably the first biotechnological application 
proposed for a psychrophilic enzyme [19]. Glycosidases are often 
used in the baking industry, but can retain residual activity after 
cooking that alters the structure of the final product during storage; 
this can be avoided by the use of psychrophilic glycosidases. 
However, despite such powerful biotechnological potential, 
psychrophilic enzymes remain under-used, partly because the cost 
of production and processing at low temperatures is higher than 
for the commercial enzymes that are presently in use. Psychrophilic 
microorganisms have also been proposed for the bioremediation of 
polluted soils and waste waters during the winter in temperate 
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countries, when the degradative capacity of the endogenous 
microflora is impaired by low temperatures. Finally, an important 
achievement in the field has been the construction of a host–vector 
system that allows the over expression of genes in psychrophilic 
bacteria [20]: expression at low temperatures prevents the 
formation of inclusion bodies and protects heat-sensitive gene 
products. 
Indian Arctic Expedition 
The Arctic and Antarctic extreme environments are the least 
explored areas on the Earth. These areas harbour unusual flora, 
fauna and microbes, which can be of great benefit to mankind. That 
is why many countries are interested in having their research base 
in the Polar Regions. Arctic expedition marks a beginning of long 
term scientific research by Indian scientists in yet another arena of 
global scientific collaborative research in the difficult Polar 
Regions, since the first Indian scientific expedition landed in 
Antarctica in 1981. Currently, Norway, Germany, France, Britain, 
Italy, Japan, the Republic of Korea and China have their research 
stations in Ny-Alesund for Arctic research. Ny-Alesund in Arctic 
has the outstanding and unique feature of being a global research 
platform to study the potential of psychrophilic microbes useful to 
the mankind. India is one among the few countries having their 
own research bases at both the poles. The Indian Arctic Expedition 
is organized by the National Centre for Antarctic and Ocean 
Research, Goa, under the Ministry of Earth Science, Govt. of India. 
In 2009 summer expedition, the authors went there as part of this 
scientific expedition. The mission of Rajiv Gandhi Centre for 
Biotechnology team was to collect microbes capable of producing 
commercially important psychrophilic enzymes and other 
biomolecules of biotechnological and medical importance. Our lab 
has a culture collection of around 300 isolates from the Arctic 
which were collected from different representative biotopes of the 
Kongsfjorden, Ny-Alesund. Molecular identification and enzyme 
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Bacterial diversity in Arctic  











The permanently frozen regions of the Arctic (North Pole) and 
Antarctic (South Pole) are really unexplored areas of the world. The 
sediment and water samples were serially diluted and plated on 
nutrient and marine agar plates and incubated at 10°C for 3-4 days. 
Isolated bacteria are identified by 16S rRNA sequencing and they 
are listed in Table 1. Janthinobacterium lividum and Kocuria spp. were 
reported for the first time from the Arctic. Arctic isolates producing 
industrially important enzymes such as lipase, amylase, protease 
and β-galactosidase at lower temperatures were also reported. 
Antibiofilm activity of Arctic Actinomycetes 
The aim of this study was to identify novel biofilm inhibitors from 
actinomycetes isolated from the Arctic against Vibrio cholerae, the 
Strain no. Identified organism 
Phylum Proteobacteria 
A1 Pseudomonas spp. (JN390949) 
A8 Pseudomonas migulae (JN390950) 
A73 Pseudomonas antarctica (JN390958) 
A74 Pseudomonas migulae (JN390959) 
A76 Pseudomonas cannabina (JN390960) 
A52 Janthinobacterium  lividum (JN390955) 
Phylum Actinobacteria 
A27 Corynebacterium  casei (JN390951) 
A40 Arthrobacter  koreensis (JN390952) 
A46 Arthrobacter  koreensis (JN390953) 
A51 Arthrobacter  koreensis (JN390954) 
A62 Arthrobacter spp. (JN390956) 
A71 Kocuria spp. (JN390957) 
A73 Nocardiopsis spp. (JF903933) 
A73 Streptomyces spp.( JF903932) 
A74 Streptomyces spp.( JF903931) 
Phylum Bacteriodetes 
A78 Flavobacterium spp. (JN390961) 
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causative agent of cholera. Studies conducted in our lab revealed 
that Arctic Actinomycetes (Streptomyces spp. and Nocardiopsis spp.) 
are good source of biofilm inhibitors against Vibrio cholera [21].The 
biofilm inhibitory activity of actinomycetes was assessed using 
biofilm assay and was confirmed using air–liquid interphase 
coverslip assay (Fig. 1). The coverslip assay results showed the 
reduction in adhesion of the cells on the coverslip surface 






Ref: Nimmy et al., 2012 
Fig 1: Air- Liquid interphase coverslip assay. a) V. cholerae  biofilm (positive 
control); b, c and d) Biofilm treated with supernatant of isolates A731, A733 and 
A745. 
Antibacterial activity of Arctic actinomycetes 
Resistance to antimicrobial agents has resulted in morbidity and 
mortality from treatment failures and increased health care costs. 
Widespread antibiotic usage exerts a selective pressure that acts as 
a driving force in the development of antibiotic resistance. The 
worldwide spread of multidrug resistant bacteria is an alarming 
issue as it renders antibiotics ineffective in treating infections. 
Hence our lab focuses on discovering novel antibiotics isolated 
from Arctic. In the present investigation, Actinomycete isolates 726, 
732, 734, 740 and 743 showed antibacterial activity towards 
Staphylococcus aureus and Vibrio cholerae. Further characterizations 
of the active fractions are in progress. 
Emergence of multidrug resistance in Arctic 
The emergence of multi-drug resistance in clinical and 
environmental strains is becoming a major problem faced by the 
clinicians and the scientific community. However, the emergence of 
multi-drug resistant bacteria in the polar ice caps has only been 
recognized recently. All isolates were tested against a set of 
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antibiotics using disc diffusion method. Results showed that 
majority of the isolates showed MDR pattern (Fig 2). All the 
bacterial isolates analysed were resistant to most of the antibiotics 
tested except a few like chloramphenicol, ciprofloxacin and 
polymyxin B. Multi drug resistant and AmpC producing bacteria 
were identified from the Arctic environment and study of its 






Fig 2: MDR profile of the bacteria isolated from Ny-Alesund, Arctic 
To summarize, though several studies have been conducted on the 
molecular basis of cold adaptation and their enzymes of 
psychrophiles, owing to their huge diversity innumerable number 
of cold adaptive mechanisms would have evolved which is really 
unexplored. Also, fundamental questions on the role of cold 
induced proteins in psychrophilic bacteria inhabiting these unique 
cold environments, play at low temperature is waiting to be 
elucidated. Last but not least, most biotechnological applications of 
psychrophiles are environment friendly and contribute to energy 
saving, both aspects being of increasing significance. In this 
context, it is suggested to conduct in-depth molecular studies on 
bacteria isolated from Polar Regions. 
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